The United States District Court for the Southern District of New York, the presiding Court in the Fosamax MDL No. 1789, has remanded several cases to state courts in the States of California, Florida, and Illinois. In a lengthy order, the District Court also taxed costs and fees against Merck for the improvident removal of the cases to federal court.
Michael Seelie, PA is representing Fosamax patients who have been diagnosed with osteonecrosis of the jaw or who have had low-energy subtrochanteric femur fractures after long-term use of Fosamax as well as zometa and aredia manufactured by Novartis. For information regarding these claims, please feel free to contact our office.
